Glucosamine

This classification denotes a nutritional supplement with the molecular formula C6H13NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N08U5BOQ1K, chemically known as mannopyranose, 2-amoino-2-deoxy-, d- (8ci) but generally known as glucosamine, which bears US NIH Compound Identifier 739. European Medicines Agency schedules Glucosamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07937MIG. The term GLUCOSAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules glucosamine in its Anatomical Therapeutic Chemical (ATC) Classification. GLUCOSAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glucosamine under HS 29329970 and SITC 51569. As of Q4 2014, GLUCOSAMINE remains the US FDA Preferred Term for this commodity. Glucosamine bears US NLM identifiers UMLS ID C0017718 and NCI Concept Code C83731. SMILES: O1C(C(O)C(O)C(N)C1O)CO.